HIV Medicine

Article	Citations
Hepatitis delta in HIV/hepatitis B coinfection: A call for action	78
Issue Information	75
Nutrition counselling and clinical outcomes in HIV: A systematic review and meta‐analysis	74
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	73
	48
Breaking down global barriers: A multinational and multi‐community approach to combat stigma and enhance mental wellbeing in people with HIV	38
Issue Information	37
Comparing effectiveness of first‐line antiretroviral therapy between peri‐urban and rural clinics in KwaZulu‐Natal, South Africa	36
The British HIV Association national clinical audit 2021: Management of HIV and hepatitis C coinfection	35
Impact of mental health service use on the HIV care cascade among women	33
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort	32
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	25
	24
Mapping frailty in people living with HIV: A nationwide study in Greece	24
Issue Information	24
	24
Issue Information	23
	23
Poster Abstracts	22
Issue Information	21
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	20
The propositive study: Immunogenicity and safety of a four‐component recombinant protein‐based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living	19
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey	19
Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV	16
The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV	16

Association of low‐level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study	15
Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV‐infected people from the French Dat'AIDS cohort: A propensity score	15
	14
	14
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	13
	12
HIV outcomes during the COVID‐19 pandemic in people of Black ethnicities living with HIV in England	12
HIV medicine editorial: Opt‐out HIV testing in the UK: Approaching the endgame?	12
Issue Information	12
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	12
Snapshot of clinical problems among people living with HIV in China	12
HIV cure: Are we going to make history?	12
Prevalence of osteoporosis in people living with HIV and risk factors associated in the cART era	11
Issue Information	11
Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, S	11
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of pulmonary opportunistic infections 2024	11
	11
Issue Information	11
Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (	11
Estimating the hospital costs of care for people living with HIV in England using routinely collected data	11
Characteristics of HIV post‐exposure prophylaxis recipients at six English sexual health clinics during COVID‐19	10
	10
The use of non‐invasive imaging modalities for the assessment of skeletal muscle quantity and quality in people with HIV: A narrative review	10
	10
	10
Tackling ageism in the healthcare system: A community perspective	10
Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low‐level viraemia in Uganda	10
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study	9
Reflections on a specialist HIV menopause service	9
Pilot evaluation of PrEP EmERGE – A novel digital health innovation designed to support sexual health clinics and HIV‐PrEP users	9
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	9
Daily ritonavir‐boosted darunavir for viral suppression in pregnancy (DRV‐P)	9
Comorbidities and co‐medications among 28 089 people living with HIV: A nationwide cohort study from 2009 to 2019 in Japan	9
Who is lost to follow‐up in HIV care? Assessment of care retention over time and the impact of COVID‐19. Longitudinal analysis of the PISCIS cohort	9
Poster Abstracts	9
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	9
Issue Information	9
Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe	9
Issue Information	9
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	8
Disparities in healthcare access and utilization among people living with HIV in China: A scoping review and meta‐analysis	8
The association between use of chemsex drugs and HIV clinic attendance among gay and bisexual men living with HIV in London	8
Characterizing heart failure and its subtypes in people living with HIV	8
Impact of training healthcare professionals in the detection and management of neuropsychiatric comorbidities in people with HIV: The CONECTAR project in Spain	8
A qualitative study of perspectives, experiences and priority outcomes for people living with HIV and frailty	8
The characteristics of men who have sex with men (MSM) using post‐exposure prophylaxis for sexual exposure (PEPSE) in the pre‐exposure prophylaxis (PrEP) era	8
Cardiovascular medication adherence testing in patients living with HIV: A single‐centre observational study	8
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment	8
	8
British HIV Association guidelines for the management of HIV‐2 2021	8

Effect of an opt‐out point‐of‐care HIV‐1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomiz	8
Issue Information	7
Early HIV viral suppression associated with subsequent 12‐month treatment success among people living with HIV in South Africa	7
Post‐partum contraception in women living with HIV	7
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	7
Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain	7
Experiences with health care services and HIV testing after sexual assault in cisgender gay, bisexual and other men who have sex with men and transgender people	7
Dolutegravir in real life: Self‐reported mental and physical health outcomes after transitioning from efavirenz‐ to dolutegravir‐based antiretroviral therapy in a prospective cohort study in Lesotho	7
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study	7
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	7
Delayed HIV diagnosis during the COVID‐19 pandemic in Poland: A call for targeted HIV testing for those under suspicion of SARS‐CoV‐2	7
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use	7
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV	7
Associations between HIV, antiretroviral therapy and preterm birth in the US Women’s Interagency HIV Study, 1995–2018: a prospective cohort	7
A qualitative study of the impact of coronavirus disease (COVID‐19) on psychological and financial wellbeing and engagement in care among men who have sex with men living with HIV in Thailand	7
The prevalence of major depressive disorder in people with HIV: Results from the All of Us Research Program	7
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	7
CROI 2024 BHIVA working group summary	6
Issue Information	6
Prevalence of anal high‐risk human papillomavirus (HR‐HPV) types in people living with HIV and a history of cancer	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men	6
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	6
Positive Outcomes: Validity, reliability and responsiveness of a novel person‐centred outcome measure for people with HIV	6
Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’	6
Treatment‐emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series	6
Comorbidities in women living with HIV: A systematic review	6
Related barriers to using HIV pre‐exposure prophylaxis among MSM: A multicentre cross‐sectional survey	6
Menopausal status, age and management among women living with HIV in the UK	6
	6
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	6
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence	6
EACS Abstracts	6
Perception of PrEP‐related stigma in PrEP users: Results from the ANRS‐PREVENIR cohort	5
Predictors for choosing doravirine‐based versus INSTI‐based regimen in ART‐naïve and ART‐experienced people with HIV in real‐world setting: Data from the Ic	5
An audit of HIV testing practice in people aged 50 years and over presenting with a known clinical indicator condition in secondary care	5
Missed opportunities for HIV pre‐exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study	5
Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	5
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	5
Participation, retention and uptake in a multicentre pre‐exposure prophylaxis cohort using online, smartphone‐compatible data collection	5
Effect of HIV infection on pre‐ and post‐liver transplant mortality in patients with organ failure	5
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process	5
Author Index	5
Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV	5
Tolerability of four‐drug antiretroviral combination therapy in primary HIV‐1 infection	5
Sero‐negative HIV, a need for presumptive HIV diagnosis in adults in developing countries	5
Issue Information	5
Public understanding and awareness of and response to monkeypox virus outbreak: A cross‐sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency	5
Estimating the risk of mortality attributable to recent late HIV diagnosis following admission to the intensive care unit: A single‐centre observational cohort study	5
Issue Information	5
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	5
‘We are fragile, but we are strong’: A qualitative study of perspectives, experiences and priority outcomes for people living with HIV and frailty	5
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey	5
Issue Information	5
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	5
Long‐acting injectable cabotegravir forPrEP: A game‐changer inHIVprevention?	5
Implementation of frailty screening for older people living with HIV in Brighton, UK	5
	4
Themed Poster Abstracts	4
Clinical outcomes of patients with and without HIV hospitalized with COVID‐19 in England during the early stages of the pandemic: a matched retrospective multi‐centre analysis (RECEDE‐C19 study)	4
	4
BritishHIVAssociation guidelines on the management of opportunistic infection in people living withHIV: Considerations in pregnancy 2024	4
Mimicking measles and syphilis: Mpox in PLHIV	4
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	4
Impact of hormonal therapy on HIV‐1 immune markers in cis women and gender minorities	4
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct‐acting antivirals—Results from the EuroSIDA	4
Issue Information	4
	4
Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART	4
Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV‐positive individuals from the HIV‐HEART Study compared with the general population	4
Issue Information	4
Immune reconstitution inflammatory syndrome‐associated Graves disease in HIV‐infected patients: clinical characteristics and response to radioactive iodine therapy	4
Evaluation of HIV antiretroviral treatment adherence in 2019 using anonymized data from the French national health insurance claims data base: The COCOVIH study	4
Statin gap in patients living with HIV: assessing dose appropriateness	4
Letter to the editor	4
Integrase strand transfer inhibitor treatment does not increase the incidence of immune reconstitution inflammatory syndrome in HIV‐infected Koreans	4
Impact of social determinants of health on time to antiretroviral therapy initiation and HIV viral undetectability for migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite	4
Changing co‐morbidity and increasing deprivation among people living with HIV: UK population‐based cross‐sectional study	4
Issue Information	4

Longitudinal analysis of new‐onset non‐AIDS‐defining diseases among people living with HIV: A real‐world observational study	4
Markers of ovarian reserve in women living with HIV: A systematic review	4
Incidence of sexually transmitted infections and association with behavioural factors: Time‐to‐event analysis of a large pre‐exposure prophylaxis (PrEP) cohort	4
Psychosocial and sexual health among men with and without HIV who have sex with men: A cross‐sectional nationwide study in Denmark	4
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	4
FRAX assessment in people ageing with HIV	4
HIV‐associated plasmablastic lymphoma: A single‐centre 12‐year experience in Kwa‐Zulu Natal, South Africa	4
External validation of the Dat'AIDS score: A risk score for predicting 5‐year overall mortality in people living with HIV aged 60 years or older	4
Comment on “A plague passing over: clinical features of the 2022 mpox outbreak in patients of colour living with HIV”	3
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	3
DORA: 48‐week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir‐ or efavirenz‐ to doravirine‐based first‐line antiretroviral th	3
	3
Issue Information	3
The value of herpes zoster prevention in people aging with HIV: A narrative review	3
Issue Information	3
A matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV	3
Clinical Case Abstracts	3
Medically assisted reproduction for people living with HIV in Europe: A cross‐country exploratory policy comparison	3
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta‐analysis	3
Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia	3
Coverage of maternal viral load monitoring during pregnancy in South Africa: Results from the 2019 national Antenatal HIV Sentinel Survey	3
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV	3
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	3
Influence of physical activity on endothelial function in people living with HIV	3
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024	3
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	3
Relapse of neurosymptomatic cerebrospinal fluid HIV RNA escape	3
Letter to the editor on “a matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV”	3
Editorial comment on: Amphetamine‐related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020	3
Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV‐1 with suppressed HIV‐1 RNA and LDL cholesterol <	3
The use of tenofovir in patients with COVID‐19	3
Obesity in women living with HIV aged 45–60 in England: An analysis of the PRIME study	3
	3
Clinical outcomes of HIV–syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study	3
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study	3
Poster Abstracts	3
Clinical staff attitudes towards opt‐out consent for blood‐borne virus screening in emergency departments in England	3
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	3
Differences in integrated assessment and management of non‐communicable diseases (NCDs) for people with HIV across the WHO European region	3
Intracellular tenofovir‐diphosphate concentrations in HIV pre‐exposure prophylaxis users who underwent bariatric surgery	3
Pre‐treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China	3
Prognostic factors for competing risk in patients with AIDS‐related Kaposi's sarcoma: A SEER population‐based study	3
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV‐negative controls: A cross‐sectional study nested within the POPPY cohort	3
Cerebrospinal fluid virology in people with HIV	3
COVID‐19 hospitalization outcomes in adults by HIV status; a nation‐wide register‐based study	3
Issue Information	3
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	3
HIV treatment cascade in regions of Peru with the highest HIV prevalence	3
	3
HIV/AIDS post‐exposure prophylaxis knowledge and uptake among health professionals in Africa: Systematic review and meta‐analysis	3
How are HIV services in the UK currently identifying and managing patients with cognitive impairment? Results of a national survey	3
Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection	3
	3
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	3
Chemsex and its impact on gay and bisexual men who have sex with men: Findings from an online survey in Belgium	3
Re‐valuation of annual cytology using HPV self‐sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK	3
Issue Information	3
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)	3
Health‐related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short‐term changes over time	3
The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study	3